A Pharmacokinetic Study of Capecitabine in Patients Undergoing Peri-Operative Chemotherapy and a Total Gastrectomy for Adenocarcinoma of the Stomach.

Trial Profile

A Pharmacokinetic Study of Capecitabine in Patients Undergoing Peri-Operative Chemotherapy and a Total Gastrectomy for Adenocarcinoma of the Stomach.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2015

At a glance

  • Drugs Capecitabine (Primary)
  • Indications Gastric cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Jul 2015 Status changed from completed to discontinued, as reported by ClinicalTrials.gov.
    • 31 Aug 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 23 Jun 2011 Planned end date changed from 31 Aug 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top